|
Clinical Trials and Observations
Citations 441-450 of 2742 total displayed.
|
Past content
(since May 1998):
|
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification
- Helmut Gadner, Nicole Grois, Ulrike Pötschger, Milen Minkov, Maurizio Aricò, Jorge Braier, Valerie Broadbent, Jean Donadieu, Jan-Inge Henter, Robert McCarter, and Stephan Ladisch, for the Histiocyte Society
Blood 2008; 111: 2556-2562.
[Abstract]
[Full text]
[PDF]
Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study
- Vinod Pullarkat, Marilyn L. Slovak, Kenneth J. Kopecky, Stephen J. Forman, and Frederick R. Appelbaum
Blood 2008; 111: 2563-2572.
[Abstract]
[Full text]
[PDF]
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
- Arend von Stackelberg, Reinhard Hartmann, Christoph Bührer, Rüdiger Fengler, Gritta Janka-Schaub, Alfred Reiter, Georg Mann, Kjeld Schmiegelow, Richard Ratei, Thomas Klingebiel, Jörg Ritter, and Günter Henze, for the ALL-REZ BFM Study Group
Blood 2008; 111: 2573-2580.
[Abstract]
[Full text]
[PDF]
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia
- Wendy Deenik, Bronno van der Holt, Gregor E. G. Verhoef, Willem M. Smit, Marie J. Kersten, Hanneke C. Kluin-Nelemans, Leo F. Verdonck, Augustin Ferrant, Anton V. M. B. Schattenberg, Jeroen J. W. M. Janssen, Pieter Sonneveld, Marinus van Marwijk Kooy, Shulamit Wittebol, Roelof Willemze, Pierre W. Wijermans, Petra H. M. Westveer, H. Berna Beverloo, Peter Valk, Bob Löwenberg, Gert J. Ossenkoppele, and Jan J. Cornelissen
Blood 2008; 111: 2581-2588.
[Abstract]
[Full text]
[PDF]
A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia
- Mitch Raponi, Jeffrey E. Lancet, Hongtao Fan, Lesley Dossey, Grace Lee, Ivana Gojo, Eric J. Feldman, Jason Gotlib, Lawrence E. Morris, Peter L. Greenberg, John J. Wright, Jean-Luc Harousseau, Bob Löwenberg, Richard M. Stone, Peter De Porre, Yixin Wang, and Judith E. Karp
Blood 2008; 111: 2589-2596.
[Abstract]
[Full text]
[PDF]
Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods
- Hagop Kantarjian, Charles Schiffer, Dan Jones, and Jorge Cortes
Blood 2008; 111: 1774-1780.
[Full text]
[PDF]
Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial
- Abderrahman Abdelkefi, Saloua Ladeb, Lamia Torjman, Tarek Ben Othman, Amel Lakhal, Neila Ben Romdhane, Halima El Omri, Moez Elloumi, Hatem Belaaj, Ramzi Jeddi, Lamia Aissaouï, Habib Ksouri, Assia Ben Hassen, Fahmi Msadek, Ali Saad, Mohamed Hsaïri, Kamel Boukef, Ahlem Amouri, Hechmi Louzir, Koussay Dellagi, and Abdeladhim Ben Abdeladhim, on behalf of the Tunisian Multiple Myeloma Study Group
Blood 2008; 111: 1805-1810.
[Abstract]
[Full text]
[PDF]
Social participation of patients with hemophilia in the Netherlands
- Iris Plug, Marjolein Peters, Eveline P. Mauser-Bunschoten, Arja de Goede-Bolder, Lily Heijnen, Cees Smit, José Willemse, Frits R. Rosendaal, and Johanna G. van der Bom
Blood 2008; 111: 1811-1815.
[Abstract]
[Full text]
[PDF]
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy
- Susan O'Brien, Farhad Ravandi, Todd Riehl, William Wierda, Xuelin Huang, Jeffrey Tarrand, Brandi O'Neal, Hagop Kantarjian, and Michael Keating
Blood 2008; 111: 1816-1819.
[Abstract]
[Full text]
[PDF]
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
- Claire Dearden, Rachel Wade, Monica Else, Sue Richards, Don Milligan, Terry Hamblin, and Daniel Catovsky, for the UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group and NCRI CLL Working Group
Blood 2008; 111: 1820-1826.
[Abstract]
[Full text]
[PDF]
|
|
